Correlation Between Kiora Pharmaceuticals and NextCure
Can any of the company-specific risk be diversified away by investing in both Kiora Pharmaceuticals and NextCure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiora Pharmaceuticals and NextCure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiora Pharmaceuticals and NextCure, you can compare the effects of market volatilities on Kiora Pharmaceuticals and NextCure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiora Pharmaceuticals with a short position of NextCure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiora Pharmaceuticals and NextCure.
Diversification Opportunities for Kiora Pharmaceuticals and NextCure
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Kiora and NextCure is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Kiora Pharmaceuticals and NextCure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NextCure and Kiora Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiora Pharmaceuticals are associated (or correlated) with NextCure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NextCure has no effect on the direction of Kiora Pharmaceuticals i.e., Kiora Pharmaceuticals and NextCure go up and down completely randomly.
Pair Corralation between Kiora Pharmaceuticals and NextCure
Given the investment horizon of 90 days Kiora Pharmaceuticals is expected to under-perform the NextCure. In addition to that, Kiora Pharmaceuticals is 1.63 times more volatile than NextCure. It trades about -0.03 of its total potential returns per unit of risk. NextCure is currently generating about 0.02 per unit of volatility. If you would invest 141.00 in NextCure on August 23, 2024 and sell it today you would lose (12.00) from holding NextCure or give up 8.51% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kiora Pharmaceuticals vs. NextCure
Performance |
| Timeline |
| Kiora Pharmaceuticals |
| NextCure |
Kiora Pharmaceuticals and NextCure Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kiora Pharmaceuticals and NextCure
The main advantage of trading using opposite Kiora Pharmaceuticals and NextCure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiora Pharmaceuticals position performs unexpectedly, NextCure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NextCure will offset losses from the drop in NextCure's long position.| Kiora Pharmaceuticals vs. ZyVersa Therapeutics | Kiora Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | Kiora Pharmaceuticals vs. Zura Bio Limited | Kiora Pharmaceuticals vs. Phio Pharmaceuticals Corp |
| NextCure vs. ZyVersa Therapeutics | NextCure vs. Sonnet Biotherapeutics Holdings | NextCure vs. Zura Bio Limited | NextCure vs. Phio Pharmaceuticals Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |